Now showing items 1-1 of 1

    • Real-world persistence of multiple sclerosis disease-modifying therapies. 

      Tallantyre, EC; Dobson, R; Froud, JLJ; St John, FA; Anderson, VM; Arun, T; Buckley, L; Evangelou, N; Ford, HL; Galea, I (John Wiley & Sons Ltd, 2024-04-03)
      BACKGROUND AND PURPOSE: Treatment persistence is the continuation of therapy over time. It reflects a combination of treatment efficacy and tolerability. We aimed to describe real-world rates of persistence on disease-modifying ...